445 related articles for article (PubMed ID: 26968398)
21. Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer.
Bonetti P; Climent M; Panebianco F; Tordonato C; Santoro A; Marzi MJ; Pelicci PG; Ventura A; Nicassio F
Oncogene; 2019 Jan; 38(3):360-374. PubMed ID: 30093634
[TBL] [Abstract][Full Text] [Related]
22. DNMT1: A key drug target in triple-negative breast cancer.
Wong KK
Semin Cancer Biol; 2021 Jul; 72():198-213. PubMed ID: 32461152
[TBL] [Abstract][Full Text] [Related]
23. Crucial and novel cancer drivers in a mouse model of triple-negative breast cancer.
Johnson JP; Kumar P; Koulnis M; Patel M; Simin K
Cancer Genomics Proteomics; 2014; 11(3):115-26. PubMed ID: 24969692
[TBL] [Abstract][Full Text] [Related]
24. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
[TBL] [Abstract][Full Text] [Related]
25. RUNX2 in mammary gland development and breast cancer.
Ferrari N; McDonald L; Morris JS; Cameron ER; Blyth K
J Cell Physiol; 2013 Jun; 228(6):1137-42. PubMed ID: 23169547
[TBL] [Abstract][Full Text] [Related]
26. The functional role of Notch signaling in triple-negative breast cancer.
Speiser JJ; Erşahin C; Osipo C
Vitam Horm; 2013; 93():277-306. PubMed ID: 23810012
[TBL] [Abstract][Full Text] [Related]
27. A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer.
Spike BT; Engle DD; Lin JC; Cheung SK; La J; Wahl GM
Cell Stem Cell; 2012 Feb; 10(2):183-97. PubMed ID: 22305568
[TBL] [Abstract][Full Text] [Related]
28. Stem Cells and the Differentiation Hierarchy in Mammary Gland Development.
Fu NY; Nolan E; Lindeman GJ; Visvader JE
Physiol Rev; 2020 Apr; 100(2):489-523. PubMed ID: 31539305
[TBL] [Abstract][Full Text] [Related]
29. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells.
Dontu G; Jackson KW; McNicholas E; Kawamura MJ; Abdallah WM; Wicha MS
Breast Cancer Res; 2004; 6(6):R605-15. PubMed ID: 15535842
[TBL] [Abstract][Full Text] [Related]
30. Mouse mammary stem cells express prognostic markers for triple-negative breast cancer.
Soady KJ; Kendrick H; Gao Q; Tutt A; Zvelebil M; Ordonez LD; Quist J; Tan DW; Isacke CM; Grigoriadis A; Smalley MJ
Breast Cancer Res; 2015 Mar; 17(1):31. PubMed ID: 25849541
[TBL] [Abstract][Full Text] [Related]
31. Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer.
Nath A; Mitra S; Mistry T; Pal R; Nasare VD
Med Oncol; 2021 Nov; 39(1):14. PubMed ID: 34812991
[TBL] [Abstract][Full Text] [Related]
32. Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis.
Li YW; Shen H; Frangou C; Yang N; Guo J; Xu B; Bshara W; Shepherd L; Zhu Q; Wang J; Hu Q; Liu S; Morrison CD; Sun P; Zhang J
Cell Cycle; 2015; 14(1):146-56. PubMed ID: 25602524
[TBL] [Abstract][Full Text] [Related]
33. ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling.
Chakrabarti R; Wei Y; Hwang J; Hang X; Andres Blanco M; Choudhury A; Tiede B; Romano RA; DeCoste C; Mercatali L; Ibrahim T; Amadori D; Kannan N; Eaves CJ; Sinha S; Kang Y
Nat Cell Biol; 2014 Oct; 16(10):1004-15, 1-13. PubMed ID: 25241036
[TBL] [Abstract][Full Text] [Related]
34. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M
Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867
[TBL] [Abstract][Full Text] [Related]
35. The Application of Non-Invasive Apoptosis Detection Sensor (NIADS) on Histone Deacetylation Inhibitor (HDACi)-Induced Breast Cancer Cell Death.
Hsu KW; Huang CY; Tam KW; Lin CY; Huang LC; Lin CL; Hsieh WS; Chi WM; Chang YJ; Wei PL; Chen ST; Lee CH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393914
[TBL] [Abstract][Full Text] [Related]
36. Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer.
Gangrade A; Pathak V; Augelli-Szafran CE; Wei HX; Oliver P; Suto M; Buchsbaum DJ
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783777
[TBL] [Abstract][Full Text] [Related]
37. Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs.
Manupati K; Dhoke NR; Debnath T; Yeeravalli R; Guguloth K; Saeidpour S; De UC; Debnath S; Das A
FEBS J; 2017 Jun; 284(12):1830-1854. PubMed ID: 28398698
[TBL] [Abstract][Full Text] [Related]
38. Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker.
O'Conor CJ; Chen T; González I; Cao D; Peng Y
Biomark Med; 2018 Jul; 12(7):813-820. PubMed ID: 29902924
[TBL] [Abstract][Full Text] [Related]
39. p38γ MAPK Is a Therapeutic Target for Triple-Negative Breast Cancer by Stimulation of Cancer Stem-Like Cell Expansion.
Qi X; Yin N; Ma S; Lepp A; Tang J; Jing W; Johnson B; Dwinell MB; Chitambar CR; Chen G
Stem Cells; 2015 Sep; 33(9):2738-47. PubMed ID: 26077647
[TBL] [Abstract][Full Text] [Related]
40. Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination.
Fonseca NA; Rodrigues AS; Rodrigues-Santos P; Alves V; Gregório AC; Valério-Fernandes Â; Gomes-da-Silva LC; Rosa MS; Moura V; Ramalho-Santos J; Simões S; Moreira JN
Biomaterials; 2015 Nov; 69():76-88. PubMed ID: 26283155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
